Dyeing and antibacterial activation with methylene blue of a cyclodextrin modified polyester vascular graft

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 9, 2014, Pages 2942-2951

  Kacem, I ^a,b   Laurent, T ^a,b   Blanchemain, N ^a,c   Neut, C ^a,d   Chai, F ^a,c   Haulon, S ^a,c   Hildebrand, H F ^a,c   Martel, B ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ LILLE 1   (France)

^c CHU de Lille   (France)

^d UNIVERSITÉ DE LILLE   (France)

Author keywords

adsorption isotherm; antibacterial activity; cyclodextrin; methylene blue; vascular prosthesis

Indexed keywords

ADSORPTION ISOTHERMS; AROMATIC COMPOUNDS; BLOOD VESSEL PROSTHESES; CYCLODEXTRINS; DYEING; DYES; GRAFTS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADSORPTION MECHANISM; ANTI-BACTERIAL ACTIVITY; BACTERICIDAL EFFECTS; GRAFT COMPATIBILITY; METHYLENE BLUE; MICROBIOLOGICAL ASSAYS; SORPTION CAPACITIES; VASCULAR PROSTHESIS;

POLYETHYLENE TEREPHTHALATES;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; METHYLENE BLUE; ANTIINFECTIVE AGENT; CELLULOSE; CYCLODEXTRIN; CYCLODEXTRIN POLYMER; POLYESTER;

ADSORPTION KINETICS; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTHERM; MICROVASCULAR ENDOTHELIAL CELL; POSTOPERATIVE INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; SUSTAINED DRUG RELEASE; ULTRAVIOLET SPECTROPHOTOMETRY; CELL LINE; CHEMISTRY; DRUG EFFECTS; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; BLOOD VESSEL PROSTHESIS; CELL LINE; CELLULOSE; CYCLODEXTRINS; HUMANS; METHYLENE BLUE; POLYESTERS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84904821006     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34965     Document Type: Article

References (48)

1. Tatterton MR, Homer-Vanniasinkam S,. Infections in vascular surgery. Injury 2011; 42: 5:S35-S41.
2. Setacci C, de Donato G, Chisci E, Setacci F, Sirignano P, Galzerano G,. Epidemiology of vascular graft infections. In:, Goeau-Brissonniere O, Kieffer E, Ricco J, editors. Vascular Surgery. Neuilly-sur-seine: Global média santé; 2009. p 10-15.
3. Sacar M, Goksin I, Baltalarli A, Turgut H, Sacar S, Onem G, Ozcan V, Adali F,. The prophylactic efficacy of rifampicine-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study. J Surg Res 2005; 129: 329-334.
4. Guillaume O, Lavigne JP, Lefranc O, Nottelet B, Coudane J, Garric X,. New antibiotic-eluting mesh used for soft tissue reinforcement. Acta Biomater 2011; 7: 3390-3397.
5. Richardson RL, Pate JW, Wolf RY, Ledes C, Hopson WB,. The outcome of antibiotic soaked arterial grafts in guinea pig wounds contaminated with E. coli or S. aureus. J Cardiovasc Thorac Surg 1970; 59: 635.
6. Kempzinski RF,. Commentary to W. S. Moore. Development of an infection-resistant vascular prosthesis. Arch Surg 1981; 116: 1403.
7. Goëau-Brissonnière O, Leport C, Bacourt F, Lebrault C, Comte R, Pechère J-C,. Prevention of Vascular graft infection by rifampin bonding to a gelatin-sealed dacron graft. Ann Vasc Surg 1991; 5: 408-412.
8. Goëau-Brissonnière O, Javerliat I, Koskas F, M. Coggia, Pechère JC,. Prothèses vasculaires imprégnées de rifampicine et infections postopératoires. Ann Chir Vasc 2011; 25: 145-154.
9. Goëau-Brissonnière O, Mercier F, Nicolas MH, Bacourt F, Coggia M, Lebrault C, Pechère JC,. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994; 19: 739-744.
10. Javerliat I, Goëau-Brissonnière O, Sivadon-Tardy V, Coggia M, Gaillard JL,. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics J Vasc Surg 2007; 46: 1026-1031.
11. Blanchemain N, Haulon S, Boschin F, Marcon-Bachari E, Traisnel M, Morcellet M, Hildebrand HF, Martel B,. Vascular prostheses with controlled release of antibiotics-Part 1: Surface modifications with cyclodextrin of PET vascular prostheses. Biomol Eng 2007; 24: 149-153.
12. Chao J, Meng D, Li J, Xu H, Huang S,. Preparation and study on the solid inclusion complex of ciprofloxacin with β-CD. Spectrochem Acta 2002 A; 58: 2809-2815.
13. Loftsson T, Brewstar ME,. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996; 85: 1017-1025.
14. Rajewski RAV,., Stella J,. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 1996; 85: 1142-1169.
15. Irie T, Uekama K,. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997; 86: 147-162.
16. Laurent T, Kacem I, Blanchemain N, Cazaux F, Neut C, Hildebrand HF, Martel B,. Cyclodextrin and maltodextrin finishing of a polypropylene abdominal wall implant for the prolonged delivery of ciprofloxacin. Acta Biomater 2011; 7: 3141-3149.
17. Chapron C, Pierre F, Querleu D, Dubuisson JB,. Major vascular injuries during gynecologic laparoscopic procedures. Gyn Obstetr Fertil 2000; 12: 880-887.
18. Chen J, Thomas C, Rentzepis C, Peter M,. Chem Phys Lett 2010; 498: 81-85.
19. Usacheva MN, Teichert MC, Biel MA,. Comparison of the methylene blue and toluidine blue bactericidal efficacy against gram-positive and gram-negative microorganisms. Laser Surg Med 2001; 29: 165-173.
20. Mainweight M, Phoenix DA, Marland J, Wareing DRA, Bolton FL,. A study of photobactericidal activity in the phenothiazinium series. Immun Med Microbiol 1997; 19: 75-80.
21. Wilson M,. Bactericidal effect of laser light and its potential use in the treatment of plaque-related diseases. Int Dental J 1994; 44: 181-189.
22. Wainwright M,. Dyes in the development of drugs and pharmaceuticals. Dyes Pigments 2008; 76: 582-589.
23. Usacheva MN, Teichert MC, Biel MA,. The role of methylene blue and toluidine blue monomers and dimers in the photoinactivation of bacteria. J Photochem Photobiol B Biol 2003; 71: 87-98.
24. Martel B, Morcellet M, Ruffin D, Ducoroy L, Weltrowski M,. Finishing of polyester fabrics by cyclodextrins by using polycarboxylic acids as crosslinking agent. J Incl Phenom Macrocycl Chem 2002; 44: 443-446.
25. El Ghoul Y, Blanchemain N, Laurent T, Campagne C, El Achari A, Roudesli S, Morcellet M, Martel B, Hildebrand HF,. Chemical, biological and microbiological evaluation of cyclodextrin finished polyamide inguinal meshes. Acta Biomater 2008; 4: 1392-1400.
26. Blanchemain N, Laurent T, Chai F, Neut C, Haulon S, Krump-Konvalinkova V, Morcellet M, Martel B, Kirkpatrick CJ, Hildebrand HF,. Polyester vascular prostheses modified with cyclodextrins and activated with antibiotics: Cytotoxicity and microbiological evaluation. Acta Biomater 2008; 4: 1725-1733.
27. Blanchemain N, Karrout Y, Tabary N, Neut C, Bria M, Siepmann J, Hildebrand HF, Martel B,. Methyl-β-cyclodextrin modified vascular prosthesis: Influence of the modification level on the drug delivery properties in different media. Acta Biomater 2011; 7: 304-314.
28. El Ghoul Y, Martel B, El Achari A, Campagne C, Razafimahefa L, Vroman I,. Improved dye ability of polypropylene fabrics finished with a β-cyclodextrin-citric acid polymer. Polym J 2010: 42: 804-811.
29. Martel B, Ruffin D, Morcellet M, Weltrowski M, Lekchiri Y,. Water soluble polymers and gels from polycondensation between cyclodextrins and polycarboxylic acids: Study of the preparation parameters. J Appl Polym Sci 2005; 97: 433-442.
30. Crini G, Ndongo Peindy H,. Adsorption of C.I. Basic Blue 9 on cyclodextrin-based material containing carboxylic groups. Dyes Pigm 2006; 70: 204-211.
31. Benesi HA, Hildebrand JH,. J Am Chem Soc 1949; 71: 2703.
32. Rose NJ, Drago RS,. Molecular addition compounds of iodine. I. An absolute method for the spectroscopic determination of equilibrium constants. J Am Chem Soc 1959; 81: 6138-6141.
33. Bergeron RJ, Roberts WP,. Boundary conditions for the Hildebrand-Benesi. Anal Biochem 1978; 90: 844-848.
34. Kuntz ID Jr, Gasparro FP, Johnston MD, Jr, Taylor RP,. Molecular interactions and the Benesi-Hildebrand equation. J Am Chem Soc 1968; 90: 4778-4781.
35. Imbenotte M, Azaroual N, Cartigny B, Vermeersch G, Lhermitte M,. Identification and quantitation of xenobiotics by 1H NMR spectroscopy in poisoning cases. Forensic Sci Inter 2000; 133: 132-135.
36. Gil VMS, Oliveira NC., On the use of the method of continuous variations, J Chem Edu 1990; 67: 473-478.
37. Connors K,. Binding Constants: The Measurement of Molecular Complex Stability. New York: Wiley; 1987.
38. Hwang TL, Shaka AJ,. Cross relaxation without TOCSY: Transverse rotating-frame Overhauser effect spectroscopy. J Am Chem Soc 1992; 114: 3157-3159.
39. ISO/EN 10993-5 / 30993-5 ISO/CEN Biological evaluation of Medical Devices-in vitro cytotoxicity assays, 2009.
40. Davis EV, Bolin VS,. Continuous cultivation of isogenous cell lines from the human embryo. Fred Proc 1960; 19: 386.
41. Frazier ME, Andrews TK., In vitro clonal growth assay for evaluating toxicity of metal salts. Trace metals in health and disease. (Edited by, Norman Kharasch,). New York 1979. p 71-81.
42. Krump-Konvalinkova V, Bittinger F, Unger RE, Peters K, Lehr HA, Kirkpatrick CJ,. Generation of human pulmonary microvascular endothelial cell lines. Lab Invest 2001; 81: 1717-1727.
43. Scott CP, Higham PA,. Antibiotic bone cement for the treatment of pseudomonas aeruginosa in joint arthroplasty: Comparison of tobramycin and gentamicin-loaded cements. J Biomed Maters Res 2003; 64B: 94-98.
44. Biedenbach DJ, Jones RN,. Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method. J Clin Microbiol 1997; 35: 3198-3202.
45. Neut C, Bulois P, Desreumaux P, Membré JM, Lederman E, Gambiez L, Cortot A, Quandalle P, Van Kruiningen HT, Colombel JF,. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroe 2002; 97: 939-946.
46. Zhang G, Shuang S, Dong C, Pan J,. Study on the interaction of methylene blue with cyclodextrin derivatives by absorption and fluorescence spectroscopy. Spectrochim Acta A 2003; 59: 2935-2941.
47. Blanchemain N, Karrout Y, Tabary N, Bria M, Neut C, Hildebrand HF, Siepmann J, Martel B,. Comparative study of vascular prostheses coated with polycyclodextrins for controlled ciprofloxacin release. Carbohydr Polym 2012; 90: 1695-1703.
48. Strathmann M, Wingender J,. Use of an oxonol dye in combination with confocal laser scanning microscopy to monitor damage to Staphylococcus aureus cells during colonisation of silver-coated vascular grafts. Intern J Antimicrobial Agents 2004; 24: 234-240.